Trial Profile
A randomized, open-label study of the effect of Cellcept [mycophenolate mofetil] on renal function after cyclosporine withdrawal in kidney transplant patients with deteriorating kidney function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2010
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Roche
- 25 Jun 2007 Status changed from in progress
- 26 Jun 2006 New trial record.